药明康德上半年TIDES收入超50亿元 已接近去年全年规模

智通财经
28 Jul
【药明康德上半年TIDES收入超50亿元 已接近去年全年规模】2025年7月28日,药明康德(603259.SH/2359.HK)披露了2025年中期报告。颇受市场关注的公司TIDES业务,上半年收入实现50.3亿元,同比增长141.6%。同时,截至6月底,TIDES在手订单同比增长48.8%。受多肽领域需求激增,目前市场多肽产能及能力成为稀缺资源,药明康德TIDES业务在2024年实现收入58亿元。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10